306 related articles for article (PubMed ID: 25578625)
1. Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: analyses from INTERMACS.
Grady KL; Naftel DC; Myers S; Dew MA; Weidner G; Spertus JA; Idrissi K; Lee HB; McGee EC; Kirklin JK
J Heart Lung Transplant; 2015 Feb; 34(2):213-21. PubMed ID: 25578625
[TBL] [Abstract][Full Text] [Related]
2. Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory Support.
White-Williams C; Fazeli PL; Kirklin JK; Pamboukian SV; Grady KL
J Heart Lung Transplant; 2020 Jan; 39(1):62-73. PubMed ID: 31787446
[TBL] [Abstract][Full Text] [Related]
3. Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support.
Grady KL; Sherri Wissman ; Naftel DC; Myers S; Gelijins A; Moskowitz A; Pagani FD; Young JB; Spertus JA; Kirklin JK
J Heart Lung Transplant; 2016 Jun; 35(6):777-88. PubMed ID: 27068037
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS.
Grady KL; Fazeli PL; Kirklin JK; Pamboukian SV; White-Williams C
J Am Heart Assoc; 2021 Jul; 10(14):e021196. PubMed ID: 34238018
[TBL] [Abstract][Full Text] [Related]
5. Causes and Consequences of Missing Health-Related Quality of Life Assessments in Patients Who Undergo Mechanical Circulatory Support Implantation: Insights From INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Grady KL; Jones PG; Cristian-Andrei A; Naftel DC; Myers S; Dew MA; Idrissi K; Weidner G; Wissman SA; Kirklin JK; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003268. PubMed ID: 29246883
[TBL] [Abstract][Full Text] [Related]
6. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
[TBL] [Abstract][Full Text] [Related]
7. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
[TBL] [Abstract][Full Text] [Related]
8. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
[TBL] [Abstract][Full Text] [Related]
9. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
10. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
[TBL] [Abstract][Full Text] [Related]
11. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
12. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
13. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
[TBL] [Abstract][Full Text] [Related]
14. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
[TBL] [Abstract][Full Text] [Related]
15. End of life for patients with left ventricular assist devices: Insights from INTERMACS.
McIlvennan CK; Grady KL; Matlock DD; Helmkamp LJ; Abshire M; Allen LA
J Heart Lung Transplant; 2019 Apr; 38(4):374-381. PubMed ID: 30642799
[TBL] [Abstract][Full Text] [Related]
16. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry.
Krim SR; Vivo RP; Campbell P; Estep JD; Fonarow GC; Naftel DC; Ventura HO
J Heart Lung Transplant; 2015 Jul; 34(7):912-20. PubMed ID: 25824553
[TBL] [Abstract][Full Text] [Related]
18. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
[TBL] [Abstract][Full Text] [Related]
19. Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation.
Grady KL; Naftel D; Stevenson L; Dew MA; Weidner G; Pagani FD; Kirklin JK; Myers S; Baldwin T; Young J
J Heart Lung Transplant; 2014 Apr; 33(4):412-21. PubMed ID: 24360203
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study.
Shah KB; Starling RC; Rogers JG; Horstmanshof DA; Long JW; Kasirajan V; Stehlik J; Chuang J; Farrar DJ; Estep JD;
J Heart Lung Transplant; 2018 Jun; 37(6):706-714. PubMed ID: 29275844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
